Metachronous metastasis occurs many years later in cases of hormone-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer, with the most common sites being the lymph nodes, bones, liver, lungs, and brain. Here, ERBB2 is linked to breast carcinoma.